BR0214835A - Uso de microorganismos para distribuição direcionada de substâncias para partes especìficas do intestino - Google Patents

Uso de microorganismos para distribuição direcionada de substâncias para partes especìficas do intestino

Info

Publication number
BR0214835A
BR0214835A BR0214835-8A BR0214835A BR0214835A BR 0214835 A BR0214835 A BR 0214835A BR 0214835 A BR0214835 A BR 0214835A BR 0214835 A BR0214835 A BR 0214835A
Authority
BR
Brazil
Prior art keywords
microorganisms
substances
specific parts
intestine
targeted distribution
Prior art date
Application number
BR0214835-8A
Other languages
English (en)
Inventor
Irene Corthesy-Theulaz
Bruce German
Raymond David Pridmore
Roberto Reniero
Ralf Zink
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR0214835A publication Critical patent/BR0214835A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"USO DE MICROORGANISMOS PARA DISTRIBUIçãO DIRECIONADA DE SUBSTâNCIAS PARA PARTES ESPECìFICAS DO INTESTINO". A presente invenção refere-se ao uso de microorganismos, em particular Lactobacilos e Bifidobactérias, para distribuir substâncias benéficas para o receptor para partes específicas de seu trato gastrointestinal. Em particular, a presente invenção refere-se a um portador ingerível contendo microorganismos com tais propriedades e ao uso do mesmo para manter o bem-estar dos indivíduos e para o tratamento e/ou profilaxia de doenças.
BR0214835-8A 2001-12-11 2002-11-25 Uso de microorganismos para distribuição direcionada de substâncias para partes especìficas do intestino BR0214835A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01129563A EP1319410A1 (en) 2001-12-11 2001-12-11 Use of micro-organisms for a directed delivery of substances to specific parts of the gut
PCT/EP2002/013244 WO2003053474A2 (en) 2001-12-11 2002-11-25 Use of micro-organisms for a directed delivery of substances to specific parts of the gut

Publications (1)

Publication Number Publication Date
BR0214835A true BR0214835A (pt) 2004-11-03

Family

ID=8179510

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214835-8A BR0214835A (pt) 2001-12-11 2002-11-25 Uso de microorganismos para distribuição direcionada de substâncias para partes especìficas do intestino

Country Status (16)

Country Link
US (1) US20050084479A1 (pt)
EP (2) EP1319410A1 (pt)
JP (1) JP2005513111A (pt)
KR (1) KR20040063942A (pt)
CN (1) CN100450550C (pt)
AU (1) AU2002352135A1 (pt)
BR (1) BR0214835A (pt)
CA (1) CA2469894A1 (pt)
IL (1) IL161658A0 (pt)
MX (1) MXPA04005346A (pt)
NO (1) NO20042152L (pt)
NZ (1) NZ533376A (pt)
PL (1) PL370439A1 (pt)
RU (1) RU2311929C2 (pt)
WO (1) WO2003053474A2 (pt)
ZA (1) ZA200405453B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1513545B1 (en) * 2002-06-19 2008-03-19 Actogenix N.V. Methods and means to promote gut absorption
US8871266B2 (en) * 2003-10-01 2014-10-28 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
JP4938005B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティックであるラクトバシラス
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
EP1957100B1 (en) 2005-11-29 2016-07-13 Intrexon Actobiotics NV Induction of mucosal tolerance to antigens
EP2125010B1 (en) 2007-01-25 2014-06-04 Actogenix N.V. Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
WO2010002241A1 (en) * 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
EP2140772A1 (en) * 2008-07-03 2010-01-06 Nestec S.A. Temperature-induced delivery of nutrients by micro-organisms in the gastrointestinal tract
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
JP6175428B2 (ja) * 2011-06-01 2017-08-02 イントレクソン・アクトバイオテイクス・エヌブイＩｎｔｒｅｘｏｎ Ａｃｔｏｂｉｏｔｉｃｓ ＮＶ 細菌のポリシストロン性発現系
KR102219239B1 (ko) * 2018-12-12 2021-02-24 피부생명공학센터 주식회사 레스베라트롤이 세포내에 축적되어 있는 미생물 제제 및 이의 제조방법
CN113403375A (zh) * 2021-02-20 2021-09-17 北京金则医学检验实验室有限公司 一种用于预测儿童肥胖症的组合物及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830463A (en) * 1993-07-07 1998-11-03 University Technology Corporation Yeast-based delivery vehicles
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
CN1153002A (zh) * 1995-12-29 1997-07-02 中国科学院上海细胞生物学研究所 抗人体消化道病原微生物免疫牛奶
AU1854297A (en) * 1996-02-14 1997-09-02 Procter & Gamble Company, The Urogenital and intestinal disorder compositions comprising substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
CN1121817C (zh) * 1996-02-28 2003-09-24 中国科学院上海细胞生物学研究所 抗人体消化道病原微生物免疫乳制品
AT406166B (de) * 1997-12-30 2000-03-27 Erber Erich Kg Mikroorganismus, verfahren zur gewinnung desselben sowie futtermittelzusatz
JPH11199495A (ja) * 1998-01-10 1999-07-27 Nichinichi Seiyaku Kk 腸溶性カプセルを用いた抗アレルギー剤
JPH11302158A (ja) * 1998-04-16 1999-11-02 Oruto Corporation:Kk 腸溶性シームカプセルを用いた整腸作用を有する健康食品
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
US6713073B1 (en) * 1998-07-24 2004-03-30 Megan Health, Inc. Method of vaccination of newly hatched poultry
EP1084709A1 (en) * 1999-09-17 2001-03-21 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Oral recombinant lactobacilli vaccines
PL365246A1 (en) * 2000-09-25 2004-12-27 Societe Des Produits Nestle S.A. Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
JP4938006B2 (ja) * 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア

Also Published As

Publication number Publication date
RU2311929C2 (ru) 2007-12-10
NO20042152L (no) 2004-09-08
WO2003053474A3 (en) 2004-02-19
MXPA04005346A (es) 2004-09-27
US20050084479A1 (en) 2005-04-21
CN100450550C (zh) 2009-01-14
WO2003053474A2 (en) 2003-07-03
RU2004121169A (ru) 2005-06-10
EP1319410A1 (en) 2003-06-18
KR20040063942A (ko) 2004-07-14
PL370439A1 (en) 2005-05-30
AU2002352135A1 (en) 2003-07-09
JP2005513111A (ja) 2005-05-12
CA2469894A1 (en) 2003-07-03
ZA200405453B (en) 2005-07-08
IL161658A0 (en) 2004-09-27
NZ533376A (en) 2006-05-26
CN1599626A (zh) 2005-03-23
EP1455836A2 (en) 2004-09-15

Similar Documents

Publication Publication Date Title
BR0214835A (pt) Uso de microorganismos para distribuição direcionada de substâncias para partes especìficas do intestino
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
BR0112685A (pt) Composição nutricional
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
BRPI0512146A (pt) métodos para o tratamento de uma infecção endobrÈnquica em um paciente, e de um paciente com fibrose cìstica, sofrendo de uma infecção endobrÈnquica
DE69615561D1 (de) Polyether-blockcopolymer micellare zusammensetzungen zur zielgerichteten verabreichung biologischer stoffe
NO20050896L (no) Probiotika for neuromuskulaere funksjoner i tarmen
BRPI0016231B8 (pt) composições compreendendo enzimas úteis para tratar ou melhorar os riscos de infecção do trato digestivo
HUP0102489A2 (hu) Biokémiai anyagok alkalmazása emberi test szerveiben található simaizomsejtek összehúzódása okozta egészségi állapotok megelőzésére és kezelésére alkalmas készítményekben
TR200400363T4 (tr) Antibiyotikten / Antibiyotiklerden oluşan bir preparatın imalatı ve kullanımı
GEP20063818B (en) Orodispersible pharmaceutical composition comprising agomelatine
DK0671942T3 (da) Farmaceutisk præparat omfattende en beta-lactamantibiotikumnedbrydende forbindelse og anvendelse deraf
BR0313239A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de doenças
TR200103819T2 (tr) kanser tedavisinde ET743 terkipleri ve kullanımları
ATE337712T1 (de) Zusammensetzung zur intestinalen verabreichung
ATE308328T1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
EE9700269A (et) Farmatseutiline kompositsioon, mis sisaldab Lactobacillus plantarum'it ja arginiini
HUP0202864A2 (en) Endoparasiticidal gel composition preparation and use thereof
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
GEP20063820B (en) Orodispersible pharmaceutical composition comprising ivabradine
BR9813856A (pt) Processos para o tratamento de uma paciente que sofre de sìndrome pré-menstrual, depressão, anemia, enxaquecas ou distúrbios alimentares e para aumentar o nìvel de serotonin em um ser humano com nìvel reduzido do mesmo no fluxo sanguìneo e composição
BR9908716A (pt) Tratamento de disfunção sexual em certos grupos de pacientes
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
GB0114672D0 (en) Pharmaceutical formulations and methods of medical treatment
BRPI0417796A (pt) preparado efervescente de uma substáncia básica de efeito medicinal

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 47/48; A61P 1/04; A61P 1/14

Ipc: A61K 47/48 (2011.01), A61P 1/04 (2011.01), A61P 1/

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.

B15K Others concerning applications: alteration of classification

Ipc: A61K 47/69 (2017.01), A61P 1/04 (2006.01), A61P 1/